Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amnestic effect of remimazolam in general anesthesia
ChiCTR2300072127Phase 4Recruiting
- Sponsor
- Hefei BOE Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam, sponsored by Hefei BOE Hospital. Primary endpoint: Postoperative memory at different time points. Started May 2023; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2300072127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072127.